首页> 外文期刊>The Internet Journal of Infectious Diseases >Antibiotic Resistance In Clinical Isolates Of Pseudomonas Aeruginosa In Enugu And Abakaliki, Nigeria
【24h】

Antibiotic Resistance In Clinical Isolates Of Pseudomonas Aeruginosa In Enugu And Abakaliki, Nigeria

机译:尼日利亚埃努古和阿巴卡利奇铜绿假单胞菌临床分离株的抗生素耐药性

获取原文
获取外文期刊封面目录资料

摘要

The resistance of Pseudomonas aeruginosa isolates from pus samples obtained from wound infection patients in Enugu and Abakaliki were investigated. The paper disc diffusion technique was used to determine the sensitivity of amoxycillin, co-trimoxazole, streptomycin, gentamicin, chloramphenicol and ciprofloxacin to the isolates. The result of the study showed that, out of fifty pus samples screened, 34(64%) yielded P. aeruginosa. The highest resistance obtained was recorded for amoxycillin (88.2%), followed by co-trimoxazole(76.5%), streptomycin(67.6%), gentamicin(58.8%), chloramphenicol(58.8%) and ciprofloxacin(23.5%). This study heralds the presence of resistant strains of P. aeruginosa in the areas of study and recommends the use of ciprofloxacin for effective management of wound infections in Enugu and Abakaliki. Introduction Pseudomonas aeruginosa is a gram negative, asporogenous, obligate aerobic, motile and oxidase positive bacilli, usually found in the intestinal tract, water, soil and sewage ( 1, 2 ). Their pathogenic potentials unveil among individuals with compromised immune system ( 3 ). They are known to be one of the major causes of nosocomial pneumonia and spread mainly through hospital equipments and healthcare workers rather than person to person ( 4, 5 ). Their frequent contamination of ventilators and hospital equipments is attributed to the fact that they are resistant to temperature extremes and drying among others ( 4 ). The infection could be invasive or toxigenic ( 6 ). P. aeruginosa is involved in the etiology of several diseases including endocarditis, meningitis, bronchopneumonia, ocular, burn and wound infections (4, 7, 8 ). Wound infection is one of the major causes of limb amputations in Nigerian children ( 9 ).The greatest challenge facing the effective management of P. aeruginosa infection is multiple drug resistance ( 10 ). Emergence of drug resistant strains of P. aeruginosa has been reported in Ibadan and Ile Ife, Nigeria ( 8, 11 ). The implication of these emerging resistance in the successful treatment of infections caused by P. aeruginosa cannot be overemphasized. This study therefore aims at determining the resistant pattern of P. aeruginosa isolates from wound infection patients in Enugu and Abakaliki to commonly used antibiotics including Ciprofloxacin, Gentamicin, Co-trimoxazole, Streptomycin, Amoxycillin and Chloramphenicol Materials And Methods Isolation of Test OrganismA total of fifty pus samples were collected from wound infection patients at the National Orthopedic Hospital Enugu (NOHE) and Ebonyi State University Teaching Hospital (EBSUTH) Abakaliki between July and September 2006. Sixteen samples were obtained from NOHE while thirty four were collected from EBSUTH using sterile swab sticks. The samples were inoculated into nutrient agar media and incubated at 37 ° C for 24 hours. Subsequently the colonies were sub-cultured using the streak plate technique ( 12 ).The isolates were identified using colony morphology, motility testing, Grams reaction and Biochemical tests as described by Cheesbrough ( 1 ) and Amadi and Ayogu, ( 13).Preparation of antibiotic discsThe antibiotic disc used for the study were prepared according to the method described by Isu and Onyeagba ( 12).The antibiotics used were Chloramphenicol, Ciprofloxacin, Amoxycillin, Streptomycin, Gentamicin and Co-trimoxazole obtained from a pharmaceutical company in Abakaliki. All the antibiotics had the official registration number of the National Agency for Food and Drug administration and Control (NAFDAC) Nigeria, with their expiration dates ranging from June 2008 to July 2010. The discs were impregnated with the antibiotics to obtain the following concentrations per disc, Ciprofloxacin (10μg), Streptomycin (30μg), Amoxycillin (30μg), Gentamicin (10μg), Chloramphenicol (30μg) and Co-trimoxazole (30μg).Antibiotic Sensitivity ScreeningOvernight old cultures of the respective isolates, adjusted to McFarland 0.5 ( 1) were
机译:研究了从Enugu和Abakaliki伤口感染患者获得的脓液样本中的铜绿假单胞菌的耐药性。纸片扩散技术用于确定阿莫西林,复方新诺明,链霉素,庆大霉素,氯霉素和环丙沙星对分离物的敏感性。研究结果表明,在筛选的五十个脓液样本中,有34(64%)个产生了铜绿假单胞菌。记录到的最高抗药性是阿莫西林(88.2%),其次是协曲莫唑(76.5%),链霉素(67.6%),庆大霉素(58.8%),氯霉素(58.8%)和环丙沙星(23.5%)。这项研究预示了该研究领域中存在铜绿假单胞菌耐药菌株,并建议使用环丙沙星有效治疗埃努古和阿巴卡利基的伤口感染。简介铜绿假单胞菌是革兰氏阴性,致孔性,专性需氧,运动和氧化酶阳性的细菌,通常存在于肠道,水,土壤和污水中(1、2)。它们的致病潜能在免疫系统受损的个体中显现出来(3)。众所周知,它们是医院内肺炎的主要原因之一,主要通过医院设备和医护人员传播,而不是通过人对人传播(4、5)。它们对呼吸机和医院设备的频繁污染归因于以下事实:它们耐极端温度和干燥(4)。感染可能是侵袭性的或有毒的(6)。铜绿假单胞菌涉及几种疾病的病因,包括心内膜炎,脑膜炎,支气管肺炎,眼,烧伤和伤口感染(4、7、8)。伤口感染是尼日利亚儿童肢体截肢的主要原因之一(9)。有效管理铜绿假单胞菌感染面临的最大挑战是多重耐药性(10)。在尼日利亚的伊巴丹和伊莱伊费尔,已经报道了铜绿假单胞菌耐药菌株的出现(8、11)。这些新出现的耐药性在成功治疗由铜绿假单胞菌引起的感染中的意义不能被过分强调。因此,本研究旨在确定从Enugu和Abakaliki伤口感染患者获得的铜绿假单胞菌分离株对常用抗生素包括环丙沙星,庆大霉素,复方新诺明,链霉素,阿莫西林和氯霉素的抗药性模式材料和方法分离测试生物的总数为五十种在2006年7月至9月之间,从Enugu国家整形外科医院和埃博尼州立大学教学医院(EBSUTH)Abakaliki的伤口感染患者中收集脓液样本。从NOHE获得了16份样本,而使用无菌棉签从EBSUTH收集了34份样本。将样品接种到营养琼脂培养基中,并在37°C下孵育24小时。随后使用条纹平板技术对菌落进行亚培养(12),并按照Cheesbrough(1)和Amadi和Ayogu(13)的描述,通过菌落形态学,活力测试,革兰氏反应和生化测试鉴定了分离株。抗生素光盘根据Isu和Onyeagba(12)所述的方法制备用于研究的抗生素光盘,使用的抗生素为氯霉素,环丙沙星,阿莫西林,链霉素,庆大霉素和复方新诺明(从阿巴卡利基的一家制药公司获得)。所有抗生素均具有尼日利亚国家食品药品监督管理局(NAFDAC)的正式注册号,其有效期为2008年6月至2010年7月。光盘中浸渍了抗生素,以使每个光盘获得以下浓度,环丙沙星(10μg),链霉素(30μg),阿莫西林(30μg),庆大霉素(10μg),氯霉素(30μg)和三曲唑(30μg)抗生素敏感性筛选分离物的过夜陈旧培养物已调整至McFarland 0.5(1)是

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号